Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / HOLX - NovaSure V5 global endometrial ablation device gets approval for use in Canada and Europe

HOLX - NovaSure V5 global endometrial ablation device gets approval for use in Canada and Europe

Hologic Inc.
  • Hologic ( NASDAQ: HOLX ) said its V5 global endometrial ablation designed to treat a wide range of cervical and uterine anatomies had been approved in Canada and Europe.
  • NovaSure V5 has a cervical seal, featuring EndoForm technology, designed to increase the sealing surface and accommodate a range of cervical canals and anatomical variability.
  • The NovaSure device enables an endometrial ablation procedure for the treatment of abnormal uterine bleeding.
  • Press Release

For further details see:

NovaSure V5 global endometrial ablation device gets approval for use in Canada and Europe
Stock Information
Company Name: Hologic Inc.
Stock Symbol: HOLX
Market: NASDAQ
Website: hologic.com
Menu
HOLX HOLX Quote HOLX Short HOLX News HOLX Articles HOLX Message Board
Get HOLX Alerts

News, Short Squeeze, Breakout and More Instantly...